Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

SIRION BIOTECH GmbH (Revvity Gene Delivery)SIRION BIOTECH GmbH (Revvity Gene Delivery)
VS
Agilent TechnologiesAgilent Technologies
SIRION BIOTECH GmbH (Revvity Gene Delivery)

SIRION BIOTECH GmbH (Revvity Gene Delivery)

Am Haag 6, Gräfelfing, Bavaria, 82166, DE

Last Update: 26/02/2026

View Profile
749/1000Moderate

Viral Vector Services from Vector Engineering and Manufacturing to Cell and Gene Therapy Development Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical app...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:25
Subsidiaries:7
12-month incidents
0
Known data breaches
0
Attack type number
0
Agilent Technologies

Agilent Technologies

5301 Stevens Creek Boulevard, Santa Clara, 95051, US

Last Update: 11/09/2026

View Profile
Between 800 and 849
http://www.agilent.com
806/1000Good

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:17,508
Subsidiaries:11
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
SIRION BIOTECH GmbH (Revvity Gene Delivery)

SIRION BIOTECH GmbH (Revvity Gene Delivery)

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Agilent Technologies

Agilent Technologies

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for SIRION BIOTECH GmbH (Revvity Gene Delivery) in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Agilent Technologies in 2026.

Incidents

Incident History - SIRION BIOTECH GmbH (Revvity Gene Delivery) (X = Date, Y = Severity)

SIRION BIOTECH GmbH (Revvity Gene Delivery) cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Agilent Technologies (X = Date, Y = Severity)

Agilent Technologies cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
SIRION BIOTECH GmbH (Revvity Gene Delivery)

SIRION BIOTECH GmbH (Revvity Gene Delivery)

Incidents
No explicit notable incidents reported.
Agilent Technologies

Agilent Technologies

Incidents
No explicit notable incidents reported.

FAQ

Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has the best AI Cybersecurity Score ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has experienced more cyber incidents in the past ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has experienced more cyber incidents this year ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has experienced at least one ransomware attack ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has experienced at least one data breach ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has experienced at least one targeted cyberattack ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has experienced at least one vulnerability ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one holds the most compliance certifications ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one holds the fewest compliance certifications ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has the most subsidiaries ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) company and Agilent Technologies company, which one has the largest number of employees ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) and Agilent Technologies, which company holds both SOC 2 Type 1 certifications ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) and Agilent Technologies, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - SIRION BIOTECH GmbH (Revvity Gene Delivery) or Agilent Technologies ?
Which company is PCI DSS compliant - SIRION BIOTECH GmbH (Revvity Gene Delivery) or Agilent Technologies ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) and Agilent Technologies, which company complies with HIPAA regulations for healthcare data ?
Between SIRION BIOTECH GmbH (Revvity Gene Delivery) and Agilent Technologies, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-93892
SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-93891
SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 7.6)
CVSS3
Base Score: 7.6
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:L
IMPACT SCORE
4.7
EXPLOITABILITY
2.3
CVE-2026-92832
SUMMARY

IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 5.1)
CVSS3
Base Score: 5.1
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.5
CVE-2026-85457
SUMMARY

IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-84418
SUMMARY

IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2